GUJARAT THEMIS BIOSYN Financial Statement Analysis
|
||
|
The Revenues of GUJARAT THEMIS BIOSYN have increased by 29.71% YoY .
The Earnings Per Share (EPS) of GUJARAT THEMIS BIOSYN has increased by 32.87 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
GUJARAT THEMIS BIOSYN Last 5 Annual Financial Results
[BOM: 506879|NSE : GUJTHEMIS]
| Standalone | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹149 Cr | ₹115 Cr | ₹91 Cr | ₹85 Cr | ₹41 Cr |
| Expenses | ₹75 Cr | ₹57 Cr | ₹50 Cr | ₹53 Cr | ₹34 Cr |
| Operating Profit (Excl OI) | ₹74 Cr | ₹58 Cr | ₹40 Cr | ₹32 Cr | ₹7.36 Cr |
| Other Income | ₹6.02 Cr | ₹4.05 Cr | ₹3.27 Cr | ₹1.70 Cr | ₹2.21 Cr |
| Interest | ₹0.20 Cr | ₹0.83 Cr | ₹0.98 Cr | ₹0.92 Cr | ₹0.16 Cr |
| Depreciation | ₹2.58 Cr | ₹2.23 Cr | ₹1.73 Cr | ₹1.36 Cr | ₹1.22 Cr |
| Profit Before Tax | ₹77 Cr | ₹59 Cr | ₹41 Cr | ₹31 Cr | ₹8.20 Cr |
| Profit After Tax | ₹58 Cr | ₹44 Cr | ₹30 Cr | ₹24 Cr | ₹6.41 Cr |
| Consolidated Net Profit | ₹58 Cr | ₹44 Cr | ₹30 Cr | ₹24 Cr | ₹6.41 Cr |
| Earnings Per Share (Rs) | ₹39.90 | ₹30.03 | ₹20.77 | ₹16.30 | ₹4.41 |
| PAT Margin (%) | 38.91 | 37.98 | 33.32 | 27.81 | 15.61 |
| ROE(%) | 45.92 | 50.35 | 53.82 | 77.99 | 41.85 |
| ROCE(%) | 61.53 | 67.91 | 67.89 | 85.96 | 44.88 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.04 | 0.19 | 0.32 |
Key Financials |
||
| Market Cap | : | ₹ 2,973.3 Cr |
| Revenue (TTM) | : | ₹ 156.3 Cr |
| Net Profit(TTM) | : | ₹ 55.0 Cr |
| EPS (TTM) | : | ₹ 7.6 |
| P/E (TTM) | : | 54.1 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| GUJARAT THEMIS BIOSYN | 0.6% | 8.7% | 182.8% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.2% | -6.1% | 55.7% |
| CIPLA | -2.5% | -5.1% | 48.6% |
| DR REDDYS LABORATORIES | -3.7% | -1.4% | 26% |
| ZYDUS LIFESCIENCES | 1.8% | 2.2% | 88.6% |
| DIVIS LABORATORIES | -0.9% | 5% | 19.2% |
| MANKIND PHARMA | -6.6% | -6.6% | NA |
| TORRENT PHARMACEUTICALS | -3.2% | 1.8% | 57.6% |
| LUPIN | -1.9% | 1.8% | 126.8% |
GUJARAT THEMIS BIOSYN Revenues
[BOM: 506879|NSE : GUJTHEMIS]
| Y-o-Y | 29.71 % |
| 5 Yr CAGR | 38.02 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹149 Cr | 29.71 | |
| Mar2022 | ₹115 Cr | 26.82 | |
| Mar2021 | ₹91 Cr | 6.39 | |
| Mar2020 | ₹85 Cr | 107.37 | |
| Mar2019 | ₹41 Cr | - | |
GUJARAT THEMIS BIOSYN Operating Profit
[BOM: 506879|NSE : GUJTHEMIS]
| Y-o-Y | 27.86 % |
| 5 Yr CAGR | 78.19 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹74 Cr | 27.86 | |
| Mar2022 | ₹58 Cr | 43.93 | |
| Mar2021 | ₹40 Cr | 26.67 | |
| Mar2020 | ₹32 Cr | 332.52 | |
| Mar2019 | ₹7.36 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -1.42 % |
| 5 Yr CAGR | 29.11 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 49.82% | -1.42 | |
| Mar2022 | 50.54% | 13.50 | |
| Mar2021 | 44.53% | 19.06 | |
| Mar2020 | 37.4% | 108.59 | |
| Mar2019 | 17.93% | - | |
GUJARAT THEMIS BIOSYN Profit After Tax
[BOM: 506879|NSE : GUJTHEMIS]
| Y-o-Y | 32.88 % |
| 5 Yr CAGR | 73.42 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹58 Cr | 32.88 | |
| Mar2022 | ₹44 Cr | 44.55 | |
| Mar2021 | ₹30 Cr | 27.48 | |
| Mar2020 | ₹24 Cr | 269.40 | |
| Mar2019 | ₹6.41 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 2.45 % |
| 5 Yr CAGR | 25.65 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 38.91 % | 2.45 | |
| Mar2022 | 37.98 % | 13.99 | |
| Mar2021 | 33.32 % | 19.81 | |
| Mar2020 | 27.81 % | 78.16 | |
| Mar2019 | 15.61 % | - | |
GUJARAT THEMIS BIOSYN Earnings Per Share (EPS)
[BOM: 506879|NSE : GUJTHEMIS]
| Y-o-Y | 32.87 % |
| 5 Yr CAGR | 73.43 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹40 | 32.87 | |
| Mar2022 | ₹30 | 44.58 | |
| Mar2021 | ₹21 | 27.42 | |
| Mar2020 | ₹16 | 269.61 | |
| Mar2019 | ₹4.41 | - | |
GUJARAT THEMIS BIOSYN Return on Capital Employed (ROCE)
[BOM: 506879|NSE : GUJTHEMIS]
| Y-o-Y | -9.39 % |
| 5 Yr CAGR | 8.21 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 61.53% | -9.39 | |
| Mar2022 | 67.91% | 0.03 | |
| Mar2021 | 67.89% | -21.02 | |
| Mar2020 | 85.96% | 91.53 | |
| Mar2019 | 44.88% | - | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Current Share Price | : | ₹409.6 |
| Current MarketCap | : | ₹ 2,973.3 Cr |
| Updated EOD on | : | May 08,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | 0.6% |
8.7% |
182.8% |
| SENSEX | -1.4% |
-0.6% |
20.1% |
GUJARAT THEMIS BIOSYN related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE HEALTHCARE | -1% | -1.1% | 52.2% |
| S&P BSE ALLCAP | -1.5% | 0.5% | 36.4% |
| S&P BSE MIDSMALLCAP | -2% | 1.7% | 59.6% |
| S&P BSE SMALL CAP | -2.5% | 1.3% | 58.3% |
No NSE index found
You may also like the below Video Courses
FAQ about GUJARAT THEMIS BIOSYN Financials
How the annual revenues of GUJARAT THEMIS BIOSYN have changed ?
The Revenues of GUJARAT THEMIS BIOSYN have increased by 29.71% YoY .
How the Earnings per Share (EPS) of GUJARAT THEMIS BIOSYN have changed?
The Earnings Per Share (EPS) of GUJARAT THEMIS BIOSYN has increased by 32.87 % YoY .
Check out Intrinsic Value of Peers of GUJARAT THEMIS BIOSYN
Compare Stock Analytics of Peers of GUJARAT THEMIS BIOSYN
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
